Your session is about to expire
← Back to Search
Behavioral Intervention
Transdiagnostic Intervention for Sleep Disorders
N/A
Waitlist Available
Led By Allison Harvey, PhD
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Publicly funded adult mental health outpatient services
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once during the sustainment phase, at least 3 months after implementation efforts have ended.
Awards & highlights
Study Summary
This trial tests if a mental health treatment can continue after initial training of providers in community mental health centers ends. It compares two versions of the treatment to see if one version works better.
Who is the study for?
This trial is for mental health professionals who work with adults in publicly funded outpatient services. They must have support from their leadership, have attended TranS-C training, and be in a sustainment period post-implementation activities for at least three months. Participants need to volunteer and consent formally.Check my eligibility
What is being tested?
The study tests the long-term use of two versions of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in community mental health centers: 'Standard' versus 'Adapted'. It aims to identify factors influencing the continued application of these treatments after initial implementation.See study design
What are the potential side effects?
As this trial involves psychological interventions rather than medications, traditional side effects are not applicable. However, there may be indirect effects related to changes in sleep patterns or stress due to adapting new treatment protocols.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am using public adult mental health services.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ once during the sustainment phase, at least 3 months after implementation efforts have ended.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once during the sustainment phase, at least 3 months after implementation efforts have ended.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adaptations to Evidence-Based Practices Scale
Organizational Resources Subscale from the Implementation Potential Scales
Outcomes and Effectiveness Scale
+3 moreSecondary outcome measures
Adaptations Checklist from the Framework for Reporting Adaptations and Modification - Expanded
Administrator Support Subscale from the Implementation Potential Scales
Creation of Sleep Treatment Materials
+7 moreOther outcome measures
Acceptability of Intervention Measure
Adaptations in Response to Cultural Backgrounds of Patients
Feasibility of Intervention Measure
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Standard TranS-CExperimental Treatment1 Intervention
Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.
Group II: Adapted TranS-CExperimental Treatment1 Intervention
The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions and is comprised of 4 cross-cutting interventions featured in every session, 5 modules that apply to the vast majority of patients, and 1 optional module used less commonly, depending on the presentation.
Find a Location
Who is running the clinical trial?
University of California, BerkeleyLead Sponsor
181 Previous Clinical Trials
721,002 Total Patients Enrolled
Allison Harvey, PhDPrincipal InvestigatorUniversity of California, Berkeley
9 Previous Clinical Trials
1,965 Total Patients Enrolled
Laurel Sarfan, PhDPrincipal InvestigatorUniversity of California, Berkeley
1 Previous Clinical Trials
286 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am using public adult mental health services.N/AI work in a community mental health center providing services directly to patients.
Research Study Groups:
This trial has the following groups:- Group 1: Adapted TranS-C
- Group 2: Standard TranS-C
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many physical venues are actively participating in this experiment?
"There exists 10 facilities offering this medical study, for example Kings County Behavioral Health in Hanford, Lake County Behavioral Health Services in Lucerne and Placer County Health and Human Services Adult System of Care in Roseville."
Answered by AI
Is there still an opportunity for participants to join this scientific experiment?
"Clinicaltrials.gov indicates that this research initiative is not currently recruiting participants, having last been updated on July 13th 2023 after first being posted April 1st 2023. At the present moment there are 111 other studies actively enrolling patients."
Answered by AI
What objectives have been set forth for this investigation?
"The purpose of this trial, which will be evaluated over a specific time-frame is to measure the effectiveness of Evidence-Based Practices Scale. Secondary objectives include an evaluation using Adaptations Checklist from the Framework for Reporting Adaptations and Modification - Expanded (scoring whether providers made any adaptations based on patient characteristics), Use of Provider Manual and Patient Workbook (assessing provider's adherence via one self-report item) and Number of Sessions with TranS-C, quantified through a 0 to 50 range scale."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger